In this episode of the In Vivo podcast, Michelle Werner, CEO of Alltrna, discusses using tRNA as a therapeutic modality for rare diseases, including those stemming from nonsense mutations.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
